Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cancer driver gene and non-coding RNA alterations as biomarkers of brain metastasis in lung cancer: A review of the literature.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 1 Nov 2021

Karimpour Mina, Ravanbakhsh Reyhaneh, Maydanchi Melika, Rajabi Ali, Azizi Faezeh, Saber Ali

Abstract excerpt

Brain metastasis (BM) is the most common event in patients with lung cancer. Despite multimodal treatments and advances in systemic therapies, development of BM remains one of the main factors associated with poor prognosis and mortality in patients with lung cancer. Therefore, better understanding of mechanisms involved in lung cancer brain metastasis (LCBM) is of great importance to suppress cancer cells and to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Lung Neoplasms

Share to Predictive Value of Tests

Share to Prognosis

Share to Risk Assessment

Share to RNA, Untranslated

Source

Identifiers

PMID: 34560543
DOI: 10.1016/j.biopha.2021.112190

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer driver gene and non-coding RNA alterations as biomarkers of brain metastasis in lung cancer: A review of the literature.PMID 34560543Read ↗

Advances in Lung Cancer Driver Genes Associated With Brain MetastasisSemantic proximity Read ↗

A Review of the Molecular Determinants of Therapeutic Response in Non-Small Cell Lung Cancer Brain Metastases.Semantic proximity Read ↗

Genes associated with increased brain metastasis risk in non–small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non–small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036)Semantic proximity Read ↗

[Targeted Therapies for Driver Gene Mutation-positive Lung Cancer Patients with Brain Metastasis].Semantic proximity Read ↗

Differences in actionable genomic alterations between brain metastases and non‑brain metastases in patients with non‑small cell lung cancerSemantic proximity Read ↗

Driver genes as predictive indicators of brain metastasis in patients with advanced NSCLC: EGFR, ALK, and RET gene mutations.Semantic proximity Read ↗

Brain parenchymal and leptomeningeal metastasis in lung cancerSemantic proximity Read ↗

Molecular profiling of non-small-cell lung cancer patients with or without brain metastases included in the randomized SAFIR02-LUNG trial and association with intracranial outcome.Semantic proximity Read ↗

Mutational landscapes of brain metastases across various histological subtypes of lung cancer.Semantic proximity Read ↗

Brain parenchymal and leptomeningeal metastasis in non-small cell lung cancer.Semantic proximity Read ↗

Lung cancer and metastasis: new opportunities and challenges.Semantic proximity Read ↗

Whole-Exome Sequencing Identifies Somatic Mutations Associated With Lung Cancer Metastasis to the BrainSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.